Capital infusion plan crucial for Bajaj Finance to be one up on rivals

Date:

The near-term stock performance may however remain range bound given a high valuation with FY24 expected price-book multiple (P/B) at around seven before capital infusion

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related